Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280939/Social-Anxiety-Disorders-SAD-Global-Clinical-Trials-Review-H2-2014.html

Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014" provides data on the Social Anxiety Disorders (SAD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Social Anxiety Disorders (SAD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Social Anxiety Disorders (SAD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Social Anxiety Disorders (SAD) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Social Anxiety Disorders (SAD) 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Social Anxiety Disorders (SAD) Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
H. Lundbeck A/S 34
Clinical Trial Overview of H. Lundbeck A/S 34
Bluefish Pharmaceuticals AB 35
Clinical Trial Overview of Bluefish Pharmaceuticals AB 35
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
Teva Pharmaceutical Industries Limited 38
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 38
Pherin Pharmaceuticals, Inc. 39
Clinical Trial Overview of Pherin Pharmaceuticals, Inc. 39
Clinical Trial Overview of Top Institutes / Government 40
Massachusetts General Hospital 40
Clinical Trial Overview of Massachusetts General Hospital 40
Duke University 41
Clinical Trial Overview of Duke University 41
Medical University of South Carolina 42
Clinical Trial Overview of Medical University of South Carolina 42
START Clinic for Mood and Anxiety Disorders 43
Clinical Trial Overview of START Clinic for Mood and Anxiety Disorders 43
Boston University 44
Clinical Trial Overview of Boston University 44
Drexel University 45
Clinical Trial Overview of Drexel University 45
University of California, San Diego 46
Clinical Trial Overview of University of California, San Diego 46
Emory University 47
Clinical Trial Overview of Emory University 47
University of California, Los Angeles 48
Clinical Trial Overview of University of California, Los Angeles 48
San Diego State University 49
Clinical Trial Overview of San Diego State University 49
Five Key Clinical Profiles 50
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 74
Contact Us 74
Disclaimer 74
Source 74

List of Tables
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Social Anxiety Disorders (SAD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Social Anxiety Disorders (SAD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Social Anxiety Disorders (SAD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Social Anxiety Disorders (SAD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Social Anxiety Disorders (SAD) Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Social Anxiety Disorders (SAD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 32
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2014* 34
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 35
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 36
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 37
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 38
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pherin Pharmaceuticals, Inc., 2014* 39
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 40
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 41
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2014* 42
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by START Clinic for Mood and Anxiety Disorders, 2014* 43
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2014* 44
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Drexel University, 2014* 45
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 46
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 47
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 48
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials Market, Global, Clinical Trials by San Diego State University, 2014* 49

List of Figures

Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Social Anxiety Disorders (SAD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Social Anxiety Disorders (SAD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Social Anxiety Disorders (SAD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Social Anxiety Disorders (SAD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Social Anxiety Disorders (SAD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Social Anxiety Disorders (SAD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 73


Read the full report:
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280939/Social-Anxiety-Disorders-SAD-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer